GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (OTCPK:GTBIF) » Definitions » Capex-to-Operating-Cash-Flow

Green Thumb Industries (Green Thumb Industries) Capex-to-Operating-Cash-Flow : 0.18 (As of Mar. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Green Thumb Industries's Capital Expenditure for the three months ended in Mar. 2024 was $-14.71 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was $84.02 Mil.

Hence, Green Thumb Industries's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 0.18.


Green Thumb Industries Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Green Thumb Industries's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Thumb Industries Capex-to-Operating-Cash-Flow Chart

Green Thumb Industries Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.62 1.42 1.13 0.98

Green Thumb Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 3.52 0.89 0.51 0.18

Competitive Comparison of Green Thumb Industries's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Thumb Industries's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Capex-to-Operating-Cash-Flow falls into.



Green Thumb Industries Capex-to-Operating-Cash-Flow Calculation

Green Thumb Industries's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-220.035) / 224.968
=0.98

Green Thumb Industries's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-14.711) / 84.023
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Thumb Industries  (OTCPK:GTBIF) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Green Thumb Industries Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Thumb Industries (Green Thumb Industries) Business Description

Traded in Other Exchanges
Address
325 West Huron Street, Suite 700, Chicago, IL, USA, 60654
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 87 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM.
Executives
Richard Reisin director 325 W. HURON STREET, SUITE 700, CHICAGO IL 60654
Hannah Scofield Buchan director 660 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10065
Ethan Nadelmann director 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Dawn Wilson Barnes director 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Bret Kravitz officer: GENERAL COUNSEL AND SECRETARY 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Jeffrey H Goldman director 325 W HURON STREET, SUITE 700, CHICAGO IL 60654
Richard A Drexler director 200 S MICHIGAN AVE, SUITE 1300, CHICAGO IL 60604
Dorri Mcwhorter director 6431 OAKTON STREET, C/O LIFEWAY FOODS, INC., MORTON GROVE IL 60053
Swati Mylavarapu director 325 W. HURON ST., SUITE 700, CHICAGO IL 60654
Mathew Faulkner officer: Chief Accounting Officer 325 W. HURON, SUITE 412, CHICAGO IL 60654
Beth Elaine Burk officer: General Counsel 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Benjamin Kovler director, 10 percent owner, officer: Chairman & CEO 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Armen Yemenidjian officer: President 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Jennifer Dooley other: Chief Strategy Officer 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Westley Moore director 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654